Please login to the form below

Not currently logged in
Email:
Password:

Redx names former Bayer exec as chairman

Frank Armstrong brings decades of experience to infectious disease biotech

Frank Armstrong, RedxRedx Pharma has appointed Dr Frank Armstrong as non-executive chairman.

Dr Armstrong has decades of experience in the pharma industry, including spells as executive VP and head of worldwide product development at Bayer and head of medical science and innovation at Merck Serono.

More recently he has worked as an independent consultant for pharma and biotech companies as well as serving on several company boards and these include current chairman positions at CardioRentis, Summit PLC and Xceleron.

He will now help guide Redx as it advances its research efforts into infectious diseases and cancer.

Dr Peter Jackson, co-founder and director at Redx, said: “[Frank's] pharma business experience and clinical insight will make a valuable contribution to our plans for further growth and he is extremely well networked internationally.”

To date this growth includes the creation of a research centre at AstraZeneca's (AZ) former site in Alderley Park, Cheshire in the UK.

Redx is also working with AZ and this week announced the two companies had signed a collaboration to research the genetic drivers of tumour growth.

4th September 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics